The ESMO Gastrointestinal Cancers Congress 2024 Exhibition represent a one-of-a-kind opportunity for organisations and companies to promote their products and services, encouraging participation and interaction among all oncology professions.
This is an important occasion to promote the value of your products and services both in an onsite and online setting.
Download the ESMO Gastrointestinal Cancers Congress 2024 Onsite Exhibition Manual
Download the ESMO Gastrointestinal Cancers Congress 2024 Virtual Exhibition Manual
Download the ESMO Gastrointestinal Cancers Congress 2024 Floorplan: Ground Floor
Download the ESMO Gastrointestinal Cancers Congress 2024 Floorplan: First Floor
Contacts
Onsite Exhibition Support
MAW (Medizinische Ausstellungs- und Werbegesellschaft)
International Exhibitions & Advertising
Freyung 6
1010 Vienna, Austria
E-mail: maw@media.co.at
Online Exhibition Support
ESMO Gastrointestinal Cancers Congress Secretariat
ESMO Head Office
E-mail: gicongress@esmo.org
Official Italian agency for AIFA procedure
AIFA rules are mandatory only for Italian Pharmaceutical Companies that will attend a congress abroad.
Any pharmaceutical company supporting or participating in a congress, is subjected to an authorisation by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124). The request of authorisation must be submitted within 60 days before the starting date of the event.
ESMO advises pharmaceutical companies to contact the Official Agency:
AIM Group International – AIM Education S.r.l.
Contact: Cristina Ghidoli
Via G. Ripamonti, 129
20141 Milan – Italy
Tel.: +39 02 56601 1
Fax.: +39 02 70048585
E-mail: aifa@aimgroup.eu